Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 UNICHEM LAB   MYLAN
EQUITY SHARE DATA
    UNICHEM LAB
Mar-23
MYLAN
Dec-18
UNICHEM LAB/
MYLAN
5-Yr Chart
Click to enlarge
High Rs4673,967-   
Low Rs2262,184-   
Sales per share (Unadj.) Rs190.71,825.4-  
Earnings per share (Unadj.) Rs-28.749.6-  
Cash flow per share (Unadj.) Rs-12.6391.3-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs344.21,974.7-  
Shares outstanding (eoy) m70.41514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.81.7 107.8%   
Avg P/E ratio x-12.162.0 -19.4%  
P/CF ratio (eoy) x-27.57.9 -349.7%  
Price / Book Value ratio x1.01.6 64.6%  
Dividend payout %00-   
Avg Mkt Cap Rs m24,3961,582,214 1.5%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m3,5640-   
Avg. sales/employee Rs Th026,833.1-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0728.6-  
INCOME DATA
Net Sales Rs m13,430939,158 1.4%  
Other income Rs m3850-   
Total revenues Rs m13,815939,158 1.5%   
Gross profit Rs m-841243,019 -0.3%  
Depreciation Rs m1,134175,847 0.6%   
Interest Rs m17345,170 0.4%   
Profit before tax Rs m-1,76422,002 -8.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m259-3,500 -7.4%   
Profit after tax Rs m-2,02225,502 -7.9%  
Gross profit margin %-6.325.9 -24.2%  
Effective tax rate %-14.7-15.9 92.2%   
Net profit margin %-15.12.7 -554.5%  
BALANCE SHEET DATA
Current assets Rs m15,885524,425 3.0%   
Current liabilities Rs m6,396382,364 1.7%   
Net working cap to sales %70.715.1 467.1%  
Current ratio x2.51.4 181.1%  
Inventory Days Days5184 61.3%  
Debtors Days Days1,60093 1,714.3%  
Net fixed assets Rs m15,911182,181 8.7%   
Share capital Rs m141500 28.2%   
"Free" reserves Rs m24,0920-   
Net worth Rs m24,2331,015,998 2.4%   
Long term debt Rs m6361,096,588 0.1%   
Total assets Rs m31,8292,725,301 1.2%  
Interest coverage x-9.21.5 -617.8%   
Debt to equity ratio x01.1 2.4%  
Sales to assets ratio x0.40.3 122.4%   
Return on assets %-5.82.6 -224.0%  
Return on equity %-8.32.5 -332.5%  
Return on capital %-6.43.2 -201.1%  
Exports to sales %69.70-   
Imports to sales %12.40-   
Net fx Rs m7,6970-   
CASH FLOW
From Operations Rs m-851195,157 -0.4%  
From Investments Rs m2,028-100,875 -2.0%  
From Financial Activity Rs m-813-90,916 0.9%  
Net Cashflow Rs m7461,617 46.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare UNICHEM LAB With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare UNICHEM LAB With: BIOFIL CHEMICALS  VENUS REMEDIES  SHELTER PHARMA  ALKEM LABORATORIES  DISHMAN CARBOGEN AMCIS  



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.